General American Investor

Broadcom is a leading designer, developer, and global supplier of a diverse array of analog and digital semiconductor solutions. Headquartered in San Jose, California, the company offers an extensive product portfolio that includes over 6,500 items targeted at various key markets such as wireless communications, wired infrastructure, industrial and automotive electronics, and consumer computing peripherals. Its products are integral to a wide range of applications, including cellular phones, data networking, telecommunications, enterprise storage, renewable energy, and factory automation. Broadcom's offerings range from simple discrete devices to complex subsystems that incorporate multiple device types and firmware, as well as mechanical hardware for optoelectronic and capacitive sensors, contributing to the scalability, agility, and security of business operations.

Kindred Biosciences is a veterinary biotechnology company based in San Francisco, California, dedicated to developing innovative therapies for dogs, cats, and horses. Founded in 2012, the company specializes in creating canine, feline, and equine antibodies aimed at treating various diseases in companion animals. Kindred Biosciences focuses on identifying compounds and targets that have previously demonstrated safety and efficacy in humans, leveraging these validated elements to develop therapeutics specifically for pets. The company maintains a diverse pipeline of novel biologics across multiple therapeutic classes, backed by robust biologics manufacturing capabilities and an extensive intellectual property portfolio. Through its efforts, Kindred Biosciences strives to provide pets with access to the same safe and effective medicines that are available to humans, reflecting its commitment to improving and saving the lives of animals.